uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Haematology.
Show others and affiliations
2015 (English)In: Leukemia and Lymphoma, ISSN 1042-8194, Vol. 56, no 5, 1385-1391 p.Article in journal (Refereed) Published
Abstract [en]

Imatinib has revolutionized the treatment of chronic myeloid leukemia (CML). We evaluated clinical outcome and cost-effectiveness, using Swedish registry data based on patients with CML diagnosed 1973-2008. Outcome from three time periods (I: 1973-1979; II: 1991-1997; III: 2002-2008) associated with symptomatic treatment, interferon-α/stem cell transplant and implementation of imatinib, respectively, were compared and a lifetime cost-effectiveness model developed. Survival data from population registries, estimated resource use from clinical practice and quality of life estimates were employed. Substantial health gains were noted over time, paralleled by increased treatment costs. Median survival was 1.9, 4.0 and 13 years during the respective time periods. The incremental cost-effectiveness ratio (ICER) between periods III and II was €52 700 per quality-adjusted life year (QALY) gained. An estimated 80% price reduction of imatinib, related to patent expiry, would reduce this ICER to €22 700. Our data from four decades reveal dramatically improved survival in CML, paralleled by ICER levels generally accepted by health authorities.

Place, publisher, year, edition, pages
2015. Vol. 56, no 5, 1385-1391 p.
National Category
URN: urn:nbn:se:uu:diva-239858DOI: 10.3109/10428194.2014.953141ISI: 000356532000047PubMedID: 25139694OAI: oai:DiVA.org:uu-239858DiVA: diva2:775453

De två första författarna delar förstaförfattarskapet.

Available from: 2015-01-02 Created: 2015-01-02 Last updated: 2015-07-27Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Höglund, Martin
By organisation
In the same journal
Leukemia and Lymphoma

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 154 hits
ReferencesLink to record
Permanent link

Direct link